Shogo Miyazawa

Serum surfactant protein D as a predictive biomarker for the efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of the phase 3 trial in Japan

Kimiyuki Ikeda, Hirofumi Chiba, Hirotaka Nishikiori et al. · Respiratory Research · 2020 · 32 citations · Full text

Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19

Takahiro Takazono, Satoki Fujita, Takuji Komeda et al. · Infectious Diseases and Therapy · 2024 · 18 citations · Full text

Ensitrelvir in patients with SARS-CoV-2: A retrospective chart review

Masaya Yamato, Masahiro Kinoshita, Shogo Miyazawa et al. · Journal of Infection and Chemotherapy · 2024 · 17 citations · Full text

Comparison of Intra-Familial Transmission of Influenza Virus From Index Patients Treated With Baloxavir Marboxil or Oseltamivir Using an Influenza Transmission Model and a Health Insurance Claims Database

Shogo Miyazawa, Takahiro Takazono, Naoki Hosogaya et al. · Clinical Infectious Diseases · 2022 · 15 citations · Full text

Comparison of the incidence of bleeding between baloxavir marboxil and other anti‐influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment‐based health insurance claims database in Japan

Azusa Hara, Kanae Hara, Takuji Komeda et al. · Pharmacoepidemiology and Drug Safety · 2021 · 11 citations · Full text